It seems there is a shortage of the ingredients needed to produce attention deficit hyperactivity disorder (ADHD) medications, and has sent some patients into a panic. The Food and Drug Administration discovered in March that they did not authorize enough of the active ingredients needed to produce medications such as Adderall and Ritalin to pharmaceutical manufacturers. These ingredients are highly regulated for their potential of abuse. The shortages affect drugs that generated a combined 24.2 million prescriptions in 2010, according to data provided by IMS Health...
No comments:
Post a Comment